Ichida T - Search Results

1

Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan.

Sato A, Sata M, Ikeda K, Kumada T, Izumi N, Asahina Y, Osaki Y, Chayama K, Kaneko S, Sakai A, Onji M, Hiasa Y, Omura T, Ozeki I, Yokosuka O, Shiina S, Itsubo M, Nishiguchi S, Hirano K, Ide T, Sakisaka S, Yamasaki T, Hidaka I, Tanaka M, Kim SR, Ichida T. Sato A, et al. Among authors: ichida t. Intern Med. 2013;52(24):2701-6. doi: 10.2169/internalmedicine.52.1180. Intern Med. 2013. PMID: 24334571 Free article.

2

Association of visceral obesity with high viral load and histological findings in elderly patients with genotype 1 chronic hepatitis C.

Tsuzura H, Genda T, Sato S, Hirano K, Kanemitsu Y, Narita Y, Kikuchi T, Iijima K, Wada R, Ichida T. Tsuzura H, et al. Among authors: ichida t. Intern Med. 2013;52(15):1665-73. doi: 10.2169/internalmedicine.52.9430. Epub 2012 Mar 1. Intern Med. 2013. PMID: 23903497 Free article.

3

Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy.

Narita Y, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, Kikuchi T, Hirano K, Iijima K, Wada R, Ichida T. Narita Y, et al. Among authors: ichida t. J Gastroenterol Hepatol. 2014 Jan;29(1):137-43. doi: 10.1111/jgh.12401. J Gastroenterol Hepatol. 2014. PMID: 24117602

4

Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan.

Orito E, Sugauchi F, Tanaka Y, Ichida T, Sata M, Tanaka E, Okanoue T, Sakugawa H, Watanabe H, Miyakawa H, Nishiguchi S, Kumada H, Ueda R, Mizokami M. Orito E, et al. Among authors: ichida t. Intervirology. 2005;48(4):239-45. doi: 10.1159/000084601. Intervirology. 2005. PMID: 15920348

5

Decompensated lamivudine-resistant hepatitis B virus-related cirrhosis treated successfully with adefovir dipivoxil allowing surgery for hepatocellular carcinoma.

Takamura M, Ichida T, Ohkoshi S, Tsubata S, Osaki A, Aoyagi T, Nomoto M, Uehara K, Terada H, Aoyagi Y. Takamura M, et al. Among authors: ichida t. Intern Med. 2007;46(7):367-71. doi: 10.2169/internalmedicine.46.6079. Epub 2007 Apr 2. Intern Med. 2007. PMID: 17409599 Free article.

6

Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.

Sato S, Genda T, Hirano K, Tsuzura H, Narita Y, Kanemitsu Y, Kikuchi T, Iijima K, Wada R, Ichida T. Sato S, et al. Among authors: ichida t. Liver Int. 2012 Oct;32(9):1382-90. doi: 10.1111/j.1478-3231.2012.02827.x. Epub 2012 Jun 11. Liver Int. 2012. PMID: 22681639 Free PMC article.

7

Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein.

Sato S, Genda T, Ichida T, Amano N, Sato S, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Hirano K, Shimada Y, Iijima K, Wada R, Nagahara A, Watanabe S. Sato S, et al. Among authors: ichida t. Int J Mol Sci. 2016 Dec 20;17(12):2143. doi: 10.3390/ijms17122143. Int J Mol Sci. 2016. PMID: 27999409 Free PMC article.

8

The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study.

Iwasaki S, Ohira H, Nishiguchi S, Zeniya M, Kaneko S, Onji M, Ishibashi H, Sakaida I, Kuriyama S, Ichida T, Onishi S, Toda G; Study Group of Intractable Liver Diseases for Research on a Specific Disease, Health Science Research Grant, Ministry of Health, Labour and Welfare of Japan. Iwasaki S, et al. Among authors: ichida t. Hepatol Res. 2008 Jun;38(6):557-64. doi: 10.1111/j.1872-034X.2007.00305.x. Hepatol Res. 2008. PMID: 18452482

9

Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm.

Takayasu K, Arii S, Sakamoto M, Matsuyama Y, Kudo M, Ichida T, Nakashima O, Matsui O, Izumi N, Ku Y, Kokudo N, Makuuchi M; Liver Cancer Study Group of Japan. Takayasu K, et al. Among authors: ichida t. Liver Int. 2013 May;33(5):762-70. doi: 10.1111/liv.12130. Epub 2013 Feb 28. Liver Int. 2013. PMID: 23445409

10

Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact.

Utsunomiya T, Shimada M, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M; Liver Cancer Study Group of Japan. Utsunomiya T, et al. Among authors: ichida t. Ann Surg. 2014 Feb;259(2):336-45. doi: 10.1097/SLA.0b013e31829291e9. Ann Surg. 2014. PMID: 23673768 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters